Annual EBIT
-$25.87 M
+$3.72 M+12.56%
31 December 2023
Summary:
Evogene annual earnings before interest & taxes is currently -$25.87 million, with the most recent change of +$3.72 million (+12.56%) on 31 December 2023. During the last 3 years, it has risen by +$65.00 thousand (+0.25%). EVGN annual EBIT is now -727.64% below its all-time high of -$1.29 million.EVGN EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$5.31 M
+$554.00 K+9.45%
30 September 2024
Summary:
Evogene quarterly earnings before interest & taxes is currently -$5.31 million, with the most recent change of +$554.00 thousand (+9.45%) on 30 September 2024. Over the past year, it has dropped by -$1.55 million (-41.40%). EVGN quarterly EBIT is now -4215.45% below its all-time high of -$123.00 thousand, reached on 31 March 2013.EVGN Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$22.97 M
-$1.55 M-7.26%
30 September 2024
Summary:
Evogene TTM earnings before interest & taxes is currently -$22.97 million, with the most recent change of -$1.55 million (-7.26%) on 30 September 2024. Over the past year, it has increased by +$1.89 million (+7.61%). EVGN TTM EBIT is now -2206.12% below its all-time high of -$996.00 thousand, reached on 30 June 2012.EVGN TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EVGN EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +12.6% | -41.4% | +7.6% |
| 3 y3 years | +0.3% | +35.1% | +24.5% |
| 5 y5 years | -24.5% | -24.4% | -20.7% |
EVGN EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +14.1% | -44.3% | +40.0% | -7.3% | +29.6% |
| 5 y | 5 years | -37.7% | +14.1% | -44.3% | +42.0% | -22.3% | +29.6% |
| alltime | all time | -727.6% | +14.1% | -4215.4% | +42.0% | -2206.1% | +29.6% |
Evogene EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$5.31 M(-9.5%) | -$22.97 M(+7.3%) |
| June 2024 | - | -$5.86 M(+59.3%) | -$21.41 M(-7.1%) |
| Mar 2024 | - | -$3.68 M(-54.7%) | -$23.06 M(-10.9%) |
| Dec 2023 | -$25.87 M(-12.6%) | -$8.12 M(+116.3%) | -$25.87 M(+4.1%) |
| Sept 2023 | - | -$3.75 M(-50.0%) | -$24.86 M(-11.2%) |
| June 2023 | - | -$7.51 M(+15.8%) | -$28.01 M(-0.2%) |
| Mar 2023 | - | -$6.49 M(-8.7%) | -$28.06 M(-5.2%) |
| Dec 2022 | -$29.59 M(-1.8%) | -$7.11 M(+3.0%) | -$29.59 M(-5.6%) |
| Sept 2022 | - | -$6.90 M(-8.7%) | -$31.33 M(-3.9%) |
| June 2022 | - | -$7.56 M(-5.6%) | -$32.61 M(+2.1%) |
| Mar 2022 | - | -$8.01 M(-9.5%) | -$31.92 M(+6.0%) |
| Dec 2021 | -$30.12 M(+16.1%) | -$8.85 M(+8.3%) | -$30.12 M(-1.0%) |
| Sept 2021 | - | -$8.18 M(+18.8%) | -$30.42 M(+10.3%) |
| June 2021 | - | -$6.88 M(+10.9%) | -$27.58 M(+8.5%) |
| Mar 2021 | - | -$6.21 M(-32.2%) | -$25.42 M(-2.0%) |
| Dec 2020 | -$25.94 M(+38.0%) | -$9.16 M(+71.6%) | -$25.94 M(+9.0%) |
| Sept 2020 | - | -$5.34 M(+13.1%) | -$23.80 M(+4.7%) |
| June 2020 | - | -$4.72 M(-29.8%) | -$22.73 M(+3.1%) |
| Mar 2020 | - | -$6.72 M(-4.3%) | -$22.04 M(+17.3%) |
| Dec 2019 | -$18.79 M(-9.6%) | -$7.02 M(+64.6%) | -$18.79 M(-1.2%) |
| Sept 2019 | - | -$4.27 M(+5.8%) | -$19.02 M(-2.6%) |
| June 2019 | - | -$4.03 M(+16.2%) | -$19.53 M(-1.5%) |
| Mar 2019 | - | -$3.47 M(-52.2%) | -$19.84 M(-4.5%) |
| Dec 2018 | -$20.78 M | -$7.26 M(+52.0%) | -$20.78 M(+2.9%) |
| Sept 2018 | - | -$4.78 M(+10.1%) | -$20.19 M(-0.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2018 | - | -$4.34 M(-1.7%) | -$20.36 M(-1.7%) |
| Mar 2018 | - | -$4.41 M(-33.8%) | -$20.70 M(-0.6%) |
| Dec 2017 | -$20.83 M(-1.2%) | -$6.67 M(+35.0%) | -$20.83 M(-7.8%) |
| Sept 2017 | - | -$4.94 M(+5.5%) | -$22.60 M(-0.2%) |
| June 2017 | - | -$4.68 M(+3.2%) | -$22.64 M(+1.2%) |
| Mar 2017 | - | -$4.54 M(-46.2%) | -$22.38 M(+6.1%) |
| Dec 2016 | -$21.09 M(+17.7%) | -$8.44 M(+69.4%) | -$21.09 M(+5.1%) |
| Sept 2016 | - | -$4.98 M(+12.7%) | -$20.07 M(+10.9%) |
| June 2016 | - | -$4.42 M(+36.0%) | -$18.10 M(+0.6%) |
| Mar 2016 | - | -$3.25 M(-56.2%) | -$17.99 M(+0.4%) |
| Dec 2015 | -$17.92 M(+17.5%) | -$7.41 M(+146.0%) | -$17.92 M(+4.9%) |
| Sept 2015 | - | -$3.01 M(-30.1%) | -$17.08 M(-3.7%) |
| June 2015 | - | -$4.31 M(+35.5%) | -$17.75 M(+7.8%) |
| Mar 2015 | - | -$3.18 M(-51.6%) | -$16.46 M(+7.9%) |
| Dec 2014 | -$15.26 M(+74.9%) | -$6.58 M(+78.8%) | -$15.26 M(+11.6%) |
| Sept 2014 | - | -$3.68 M(+21.6%) | -$13.67 M(+11.6%) |
| June 2014 | - | -$3.02 M(+53.2%) | -$12.24 M(+17.0%) |
| Mar 2014 | - | -$1.98 M(-60.4%) | -$10.47 M(+21.5%) |
| Dec 2013 | -$8.72 M(+179.0%) | -$4.99 M(+121.4%) | -$8.61 M(+60.4%) |
| Sept 2013 | - | -$2.25 M(+80.2%) | -$5.37 M(+38.0%) |
| June 2013 | - | -$1.25 M(+916.3%) | -$3.89 M(+7.0%) |
| Mar 2013 | - | -$123.00 K(-92.9%) | -$3.64 M(+3.5%) |
| Dec 2012 | -$3.13 M(-1.8%) | -$1.74 M(+125.0%) | -$3.52 M(+98.5%) |
| Sept 2012 | - | -$775.00 K(-22.2%) | -$1.77 M(+77.8%) |
| June 2012 | - | -$996.00 K | -$996.00 K |
| Dec 2011 | -$3.18 M | - | - |
FAQ
- What is Evogene annual earnings before interest & taxes?
- What is the all time high annual EBIT for Evogene?
- What is Evogene annual EBIT year-on-year change?
- What is Evogene quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Evogene?
- What is Evogene quarterly EBIT year-on-year change?
- What is Evogene TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Evogene?
- What is Evogene TTM EBIT year-on-year change?
What is Evogene annual earnings before interest & taxes?
The current annual EBIT of EVGN is -$25.87 M
What is the all time high annual EBIT for Evogene?
Evogene all-time high annual earnings before interest & taxes is -$1.29 M
What is Evogene annual EBIT year-on-year change?
Over the past year, EVGN annual earnings before interest & taxes has changed by +$3.72 M (+12.56%)
What is Evogene quarterly earnings before interest & taxes?
The current quarterly EBIT of EVGN is -$5.31 M
What is the all time high quarterly EBIT for Evogene?
Evogene all-time high quarterly earnings before interest & taxes is -$123.00 K
What is Evogene quarterly EBIT year-on-year change?
Over the past year, EVGN quarterly earnings before interest & taxes has changed by -$1.55 M (-41.40%)
What is Evogene TTM earnings before interest & taxes?
The current TTM EBIT of EVGN is -$22.97 M
What is the all time high TTM EBIT for Evogene?
Evogene all-time high TTM earnings before interest & taxes is -$996.00 K
What is Evogene TTM EBIT year-on-year change?
Over the past year, EVGN TTM earnings before interest & taxes has changed by +$1.89 M (+7.61%)